Zining Wang
Zining Wang publishes mostly in Cardiology and Cardiovascular Medicine, Hematology and Surgery, on topics such as Antiplatelet Therapy and Cardiovascular Diseases, Atrial Fibrillation Management and Outcomes and Military Technology and Strategies.
- World rank
- #4,813,790 of 7,710,434 ranked researchers
- Rank in China
- #725,908 of 978,568
- Works
- 61
- Citations
- 282
- Citations per work
- 4.6
What does Zining Wang research?
Zining Wang's work is mostly in Medicine (38%), Immunology and Microbiology (4%), Engineering (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3354.1%
- Health Sciences2337.6%
- Medicine2337.6%
- Life Sciences34.5%
- Physical Sciences23.8%
- Engineering23.8%
- 1Cardiology and Cardiovascular Medicine18% of their works
- 2Hematology8% of their works
- 3Surgery6% of their works
- 4Pulmonary and Respiratory Medicine5% of their works
- 5Immunology4% of their works
- 6Aerospace Engineering4% of their works
Research topics
- Antiplatelet Therapy and Cardiovascular Diseases
- Atrial Fibrillation Management and Outcomes
- Military Technology and Strategies
- Acute Myocardial Infarction Research
- Linguistic, Cultural, and Literary Studies
- Legal and Regulatory Analysis
- Venous Thromboembolism Diagnosis and Management
- Coronary Interventions and Diagnostics
Which keywords describe Zining Wang's research?
The keywords of their largest research topics: Percutaneous Coronary Intervention, Guidelines, Aspirin, Clopidogrel, Anticoagulant Therapy, Atrial Fibrillation, Acute Coronary Syndromes and Air Force.
- Venous Thromboembolism
- Coronary Stents
- Transport Policy
- Modernization
- Islam
- Air Force
- Atrial Fibrillation
- Clopidogrel
- Guidelines
- Percutaneous Coronary Intervention
- Aspirin
- Anticoagulant Therapy
- Acute Coronary Syndromes
- Culture
- Legal Regulation
- Myocardial Infarction
- Antithrombotic Therapy
- Myocardial Revascularization
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Percutaneous Coronary Intervention142 topics
- Guidelines132 topics
- Aspirin91 topic
- Clopidogrel91 topic
- Anticoagulant Therapy71 topic
- Atrial Fibrillation71 topic
- Acute Coronary Syndromes61 topic
- Air Force61 topic
- Culture61 topic
- Islam61 topic
- Legal Regulation61 topic
- Modernization61 topic
- Myocardial Infarction61 topic
- Transport Policy61 topic
- Antithrombotic Therapy51 topic
- Coronary Stents51 topic
- Myocardial Revascularization51 topic
- Venous Thromboembolism51 topic
Where does Zining Wang work?
Zining Wang's main affiliation in the publication record is Peking University, China.
How many publications and citations does Zining Wang have?
OpenAlex counts 61 works and 282 citations for Zining Wang, an h-index of 9, ranking #4,813,790 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Zining Wang
- zining-wang-qingdao-university-of-science-and-technology
- zining-wang-sun-yat-sen-university
- zining-wang-sun-yat-sen-university-china
- zining-wang-zhejiang-university
- zining-wang-beihang-university
- zining-wang
- zining-wang-university-of-california-berkeley
- zining-wang-sichuan-university
- zining-wang-chuo-university
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Zining Wang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.